The global Infectious Disease Diagnostics Market is poised for significant growth, with its valuation increasing from USD 41.79 billion in 2022 to a projected USD 57.91 billion by 2031, at a CAGR of 3.69% during the forecast period (2023-2031), according to a report by Straits Research.
The rising prevalence of infectious diseases, coupled with advancements in diagnostic technologies, is expected to drive market expansion. Increasing awareness, early detection programs, and government initiatives for infectious disease management further contribute to this upward trajectory.
For a full PDF sample copy of the report, visit: https://straitsresearch.com/report/infectious-disease-diagnostics-market/request-sample
Market Drivers
- Rising incidence of infectious diseases globally
- Technological advancements in diagnostic testing
- Increased government and private sector funding for healthcare infrastructure
- Growing adoption of molecular diagnostic techniques
- Demand for rapid and accurate diagnostic solutions
Key Developments in the Infectious Disease Diagnostics Market
- Continuous innovations in molecular diagnostics and point-of-care testing
- Strategic collaborations and partnerships among key players
- Expansion of product portfolios by leading companies
- Growth in home-based and self-testing diagnostic solutions
- Increased regulatory approvals for novel diagnostic tests
Top Key Players in the Infectious Disease Diagnostics Market
- Biomerieux Inc.
- Abbott Laboratories
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
- Quidel Corporation
- Diasorin Spa (Luminex Corporation)
- Trinity Biotech Plc
- Quest Diagnostics
- Sysmex Corporation
- Ortho-Clinical Diagnostics
- Seegene Inc
For detailed market segmentation, visit: https://straitsresearch.com/report/infectious-disease-diagnostics-market/segmentation
Market Segmentation Analysis
By Applications:
- Hepatitis
- Human Immunodeficiency Virus (HIV)
- Chlamydia Trachomatis Genital Infection
- Gonorrhea (CT/NG)
- Hospital-Acquired Infections
- Human Papillomavirus (HPV)
- Tuberculosis (TB)
- Influenza
By Product:
- Assays, Kits, and Reagents
- Instruments
- Services and Software
By Technology:
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Immunodiagnostics
- DNA Microarray
- Clinical Microbiology
- DNA Sequencing and Next-Generation Sequencing (NGS)
For inquiries or customization before purchasing, visit: https://straitsresearch.com/buy-now/infectious-disease-diagnostics-market
About Straits Research
Straits Research is a leading provider of business intelligence solutions, specializing in research, analytics, and advisory services. The company delivers comprehensive market insights to help businesses make data-driven decisions and stay ahead in the industry.
Contact Us:
Straits Research
Email: [email protected]
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
